155 related articles for article (PubMed ID: 16201183)
1. Liver transplantation for patients with hepatitis B virus-related diseases.
Huang J; He X; Zhu X; Chen G
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):737-41. PubMed ID: 16201183
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China.
Huang J; He X; Chen G; Zhu X; Lu M; Wang G; Fu Y; Yang Y; Guan X
Chin Med J (Engl); 2002 Apr; 115(4):543-8. PubMed ID: 12133294
[TBL] [Abstract][Full Text] [Related]
3. [Orthotopic liver transplantation: report of 70 cases].
Chen G; He X; Zhu X
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):679-83. PubMed ID: 11769601
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
[TBL] [Abstract][Full Text] [Related]
5. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
6. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
10. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
ViganĂ² M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.
Kim JH; Park JW; Koh DW; Lee WJ; Kim CM
Liver Int; 2009 Feb; 29(2):203-7. PubMed ID: 18662281
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of hepatitis B relapse after liver transplantation.
Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
[TBL] [Abstract][Full Text] [Related]
13. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of hepatitis B virus recurrence after liver transplantation.
Han YS; Lee SK; Joh JW; Kim SJ; Kwon CH; Park JW; Kim DJ; Park JB
Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatitis B-related cirrhosis: recent advances.
Sugawara Y; Makuuchi M
J Hepatobiliary Pancreat Surg; 2006; 13(5):378-81. PubMed ID: 17013710
[TBL] [Abstract][Full Text] [Related]
16. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
17. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy for hepatitis B virus associated hepatic failure.
Wang YM; Tang YZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]